Analyst firms · William Blair · ARGX
William Blair ARGX price target and rating history
argenx SE (ARGX) · Health Care
William Blair rates argenx SE (ARGX) Outperform, as of its latest action on Nov 1, 2024. It has published 3 rating actions on ARGX since December 2022, including 1 upgrade and 1 downgrade. Across 3 firms with a ARGX price target in the last 12 months, the median target is $1,185.
- Current rating
- Outperform
- Price target
- Not stated
- Median target, all firms
- $1,185
- Actions on ARGX
- 3
Every William Blair rating on ARGX
- Nov 1, 2024
- Dec 20, 2023
- Dec 7, 2022
How other firms rate ARGX
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| UBS | Buy | $1,400 | Aug 26, 2026 |
| Deutsche Bank | Hold | Aug 24, 2026 | |
| Guggenheim | Buy | $1,185 | Aug 4, 2026 |
| Robert W. Baird | Neutral | $858 | Dec 18, 2025 |
| Wolfe Research | Peer Perform | Nov 24, 2025 |
Questions about William Blair and ARGX
- What is William Blair's rating on ARGX?
- William Blair rates ARGX Outperform, a bullish rating, as of Nov 1, 2024.
- When did William Blair last change its view on ARGX?
- On Nov 1, 2024, William Blair upgrades to Outperform from Mkt Perform.
- How does William Blair's ARGX target compare with other analysts?
- Across 3 firms with a ARGX price target in the last 12 months, the median target is $1,185.
More ARGX rating histories
All William Blair ratingsARGX news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.